Evidence map›Paper›PMID 37621813›Full record

ArticleCureus2023

Toe Gangrene as the First Presenting Symptom of Essential Thrombocythemia: A Case Report.

Mahmoud M Altayyan, Mohammad Abu-Tineh, Awni Alshurafa, Mohammed Abdulgayoom, Mohammad Afana, Khalid Ahmed, Haneen A Toba, Mohamed A Yassin

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mahmoud M AltayyanDepartment of Medical Education, Hamad Medical Corporation, Doha, QAT.
Mohammad Abu-TinehDepartment of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.
Awni AlshurafaDepartment of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.
Mohammed AbdulgayoomDepartment of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.
Mohammad AfanaDepartment of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.
Khalid AhmedDepartment of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.
Haneen A TobaDepartment of Medical Education, Hamad Medical Corporation, Doha, QAT.
Mohamed A YassinDepartment of Medical Oncology, Hematology, and Bone Marrow Transplant, National Center for Cancer Care and Research, Doha, QAT.
National Center for Cancer Care and Research · QAHamad Medical Corporation · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essential thrombocythemia is a myeloproliferative neoplasm. Thrombosis and bleeding complications are common with myeloproliferative neoplasms, particularly essential thrombocythemia and polycythemia vera. Here, we report the case of a 52-year-old female who presented initially with painful toe swelling and discoloration. Initial imaging showed a small abscess. An incision and drainage, and debridement of toe dry gangrene were performed twice in two months with no improvement in her complaint and worsening discoloration, ending in a toe amputation. Two years later, the patient was referred to a hematology clinic for a high platelet count. On review of her medical records, the patient had the same numbers during the initial presentation. The patient's condition was diagnosed retrogradely by a hematologist as essential thrombocythemia. This case sheds light on myeloproliferative neoplasm as a differential diagnosis in patients with atypical thrombosis. Thinking in such a way could have diagnosed our patient two years earlier.

Indexed as

ischemialower limbmyeloproliferative neoplasmthrombocythemiathrombosis

Identifiers

PMID37621813
PMCPMC10446243
OpenAlexW4385216110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.